US 8075881
Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
granted A61KA61K2035/124A61K35/34
Quick answer
US patent 8075881 (Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure) held by Regents of the University of Minnesota expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2035/124, A61K35/34, A61P, A61P9/00